Significant differences were found with reference to the percentage of CD4 + CD25 + FOXP3+ Treg lymphocytes in malignant and non-malignant tumors between individual groups of patients (Kruskal-Wallis test; p = 0.003). The gene discussed is CD4; the disease is cancer.